AVLN
Avalyn Pharma Inc.
Set alert
25.63 USD -0.08 -0.31%
24.85 Day range 26.17
23.33 52-week range 39.25
- YTD
- -13.09%
- 1 year
- -13.09%
- Open
- 25.71
- Prev close
- 25.71
- Mkt cap
- 1.14B
- Vol
- 343.50K
- Avg vol
- 281.23K
- EPS
- -2.47
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 24.85
- High
- 26.17
- Forward P/E
- -9.93
- Beta
- 0.00
- Short ratio
- 7.21
- Inst. own
- 104.07%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 11, 2026
- 50-d avg
- 30.39
- 200-d avg
- 30.03
- 1y target
- 61.80
Financial health
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 2
Valuation
P/E -14.5×
FY 2025 5y median -14.5× FY 2025
P/S 0.0×
FY 2025 5y median 0.0× FY 2025
P/B -5.2×
FY 2025 5y median -5.2× FY 2025
P/FCF -15.1×
FY 2025 5y median -15.1× FY 2025
EV/EBITDA -13.0×
FY 2025 5y median -13.0× FY 2025
EV/Sales 0.0×
FY 2025 5y median 0.0× FY 2025
FCF Yield -6.6%
FY 2025 5y median -6.6% FY 2025
Profitability
Gross Margin 0.0%
FY 2025 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2025 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2025 5y median 0.0% FY 2025
ROE 35.7%
FY 2025 5y median 35.7% FY 2025
ROIC -67.5%
FY 2025 5y median -67.5% FY 2025
ROA -57.2%
FY 2025 5y median -57.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2025 FY 2025
Operating Income 0.0%
FY 2025 FY 2025
EPS (diluted) 0.0%
FY 2025 FY 2025
Free Cash Flow 0.0%
FY 2025 FY 2025
Financial Health
Current Ratio 10.2×
FY 2025 5y median 10.2× FY 2025
Quick Ratio 10.2×
FY 2025 5y median 10.2× FY 2025
Debt / Equity -0.0×
FY 2025 5y median -0.0× FY 2025
Net Debt / EBITDA 0.6×
FY 2025 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2025 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2025 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2025 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31